Patent: 9,248,194
✉ Email this page to a colleague
Summary for Patent: 9,248,194
| Title: | Affinity peptides toward infliximab |
| Abstract: | We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab. |
| Inventor(s): | Salick Ryan; Daphne Ann (Manalapan, NJ), Kehoe; John (Spring House, PA), Wheeler; John (Spring House, PA), Yang; Chunlin (Belle Mead, NJ), Creasy; Abla (Morristown, NJ) |
| Assignee: | Janssen Biotech, Inc. (Horsham, PA) |
| Application Number: | 14/338,391 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,248,194
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2039-03-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
